Overview


According to FutureWise analysis, the market for Prochlorperazine is expected to grow with a CAGR of 3.55% over the forecast period 2024-2032, and reach a market value of US$ 1.93 billion by 2031.

Prochlorperazine maleate is a medication that belongs to a class of drugs known as phenothiazines. It works by affecting specific chemicals in the brain, particularly dopamine, which is involved in regulating various functions, including mood, behaviour, and the sensation of nausea. It's often prescribed to alleviate nausea and vomiting associated with conditions like motion sickness, chemotherapy, surgery, and certain gastrointestinal disorders. Prochlorperazine can effectively treat symptoms of vertigo, which is caused by inner ear problems or other vestibular disorders. In some cases, it may also be used to help relieve the symptoms of severe migraines.

Prochlorperazine is available in different dosage forms to cater to diverse patient needs. The oral tablets of prochlorperazine maleate are a common form of administration. These tablets are designed for ingestion, allowing for systemic absorption through the digestive tract. They are typically taken with water, and the prescribing healthcare professional determines the dosage based on the exact condition being treated and the individual patient's requirements. Rectal suppositories are another formulation of prochlorperazine maleate. These are solid medications introduced into the rectum, where they dissolve and are absorbed through the rectal mucosa. In addition to oral and rectal formulations, prochlorperazine maleate is also available in injectable forms. Injectable formulations allow for rapid medication delivery into the bloodstream, making them valuable in situations where immediate relief or precise dosing is crucial. This form is often used in clinical settings, such as hospitals or clinics, and is administered by a healthcare professional.

FutureWise Market Research has published a report that provides an insightful analysis prochlorperazine maleate market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts prochlorperazine maleate market estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Novartis AG
  • AstraZeneca plc
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Sanofi S.A
  • AbbVie Inc.
  • Johnson & Johnson
  • Boehringer Ingelheim International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Prochlorperazine Maleate Market:

  • In 2022, Glenmark Pharmaceuticals acquired the rights to market and distribute prochlorperazine maleate tablets in India from Mylan Pharmaceuticals.
  • In 2022, Aurobindo Pharma announced the launch of its generic version of prochlorperazine maleate tablets in the United States.

The increasing prevalence of conditions such as chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV) has propelled the demand for Prochlorperazine Maleate, a potent antiemetic drug. As these adverse side effects are common in patients undergoing cancer treatments or surgical procedures, there's a critical need for effective solutions. Prochlorperazine Maleate, renowned for its efficacy in alleviating nausea and vomiting, has emerged as a vital tool in providing much-needed relief for individuals grappling with these debilitating symptoms, thus driving its prominence in the pharmaceutical market. This rise in demand emphasizes its essential function in improving the quality of life for patients undergoing these critical medical interventions. Additionally, ongoing research and development in pharmaceuticals may lead to the development of more effective and efficient formulations of Prochlorperazine Maleate, which may further drive market growth. Researchers seek to improve the drug's bioavailability and dosage accuracy through advanced technologies and methodologies and minimize potential side effects. These advancements not only boost the therapeutic benefits for patients but also drive the market position of prochlorperazine maleate as an advanced solution. The evolution towards more refined formulations ensures a competitive edge and positions it as an indispensable component in the treatment arsenal against nausea and vomiting, further fueling the market growth. However, the adverse side effects, including drowsiness, dizziness, and extrapyramidal symptoms, pose a notable restraint on the widespread use of prochlorperazine maleate. While effective in managing nausea and vomiting, these adverse reactions might be particularly demanding for certain patient populations, such as those engaged in activities requiring increased alertness or individuals with pre-existing conditions that may exacerbate these effects. This may lead to a cautious approach by healthcare providers when prescribing drugs, potentially limiting its application in specific patient populations.

By Indication

  • Nausea and Vomiting Management
  • Vertigo
  • Mental Health Disorders (e.g., Schizophrenia)

By Dosage Form

  • Oral Tablets
  • Rectal Suppositories
  • Injectable Formulations

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to the sophisticated healthcare infrastructure, well-established pharmaceutical sector, huge patient population, and high prevalence of antiemetic disorders such as nausea and vomiting, vertigo, and certain mental health disorders in the US contributed to the demand for the drug discount card market. In addition, the development of combination therapies, advancements in drug delivery technologies, increasing research and development activities, and product launches and approvals are factors driving the market growth in the area over the projection period. For instance, in 2022, Aurobindo Pharma received approval from the US FDA for its generic version of Compazine Injectable. This product is available in 5 mg/mL and 10 mg/mL strengths.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Prochlorperazine Maleate Market By Indication, By Dosage Form, By Distribution Channel, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Prochlorperazine Maleate Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Prochlorperazine Maleate Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Prochlorperazine Maleate Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Prochlorperazine Maleate Market, By Indication Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Nausea and Vomiting Management
        2. Vertigo
        3. Mental Health Disorders (e.g., Schizophrenia)

  • 8.  Prochlorperazine Maleate Market, By Dosage Form Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Oral Tablets
        2. Rectal Suppositories
        3. Injectable Formulations

  • 9.  Prochlorperazine Maleate Market, By Distribution Channel Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies

  • 10.  Prochlorperazine Maleate Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Ambulatory Surgical Centers
        4. Homecare Settings

  • 11.  North America Prochlorperazine Maleate Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 12.  Latin America Prochlorperazine Maleate Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 13.  Europe Prochlorperazine Maleate Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 14.  Asia Pacific Prochlorperazine Maleate Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032  

  • 15.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 16.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GlaxoSmithKline plc
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Pfizer Inc.
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Novartis AG
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. AstraZeneca plc
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Teva Pharmaceutical Industries Ltd.
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Mylan N.V.
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Sanofi S.A
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. AbbVie Inc.
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Johnson & Johnson
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Boehringer Ingelheim International GmbH
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. Sun Pharmaceutical Industries Ltd.
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Lupin Limited
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Eli Lilly and Company
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. Merck & Co., Inc.
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. Bristol-Myers Squibb Company
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients